Nanoparticles for Clinical Applications, page-3

Hi entrpylord, yes have look back through things.
I am pretty happy to sit with it fo a couple of reasons...

- investment appropriate with risk
- enough new blood in business
- management putting hand in their pockets with substantial enough investments
- Ferronova is ran separately to PVL and has pretty robust management and positioning in its own right.
- outside of Ferronova there is some investments that look decent enough in their own right.

It’s not without precedent for a company growth to drag on and someone with a bit more of a push can get it moving. Wether this is to skill or dumb luck who knows..

But all these risks and rewards need to be managed by us when investing.

This looks cheap in a market with many stocks looking overpriced...

Time will tell.